Chapter 21: Glycogen Metabolism

Glycogen Metabolism explains why glucose is stored as the branched polymer glycogen—primarily in the liver and skeletal muscle—to avoid disrupting cellular osmotic balance. The text outlines the enzymatic steps of glycogen degradation, or glycogenolysis, initiated by glycogen phosphorylase, which uses pyridoxal phosphate (PLP) to cleave alpha-1,4-glycosidic bonds and release glucose 1-phosphate. The process requires remodeling enzymes, specifically a transferase and an alpha-1,6-glucosidase (debranching enzyme), to handle branch points, followed by phosphoglucomutase to convert the product to glucose 6-phosphate. A key distinction is drawn between liver and muscle metabolism; the liver possesses glucose 6-phosphatase to release free glucose into the blood for systemic use, whereas muscle retains glucose 6-phosphate for its own energy needs during contraction. The narrative transitions to glycogen synthesis, or glycogenesis, which utilizes the activated precursor UDP-glucose and the enzyme glycogen synthase to form alpha-1,4 linkages, while a branching enzyme creates alpha-1,6 linkages, all built upon a glycogenin protein primer. Central to this chapter is the complex, reciprocal regulation of these pathways to ensure they do not cycle futilely. This involves allosteric control, such as AMP activating muscle phosphorylase during exercise, and hormonal signal transduction cascades involving epinephrine, glucagon, and insulin. The text describes how cyclic AMP and protein kinase A (PKA) trigger phosphorylation events that activate breakdown and inhibit synthesis, while insulin and protein phosphatase 1 (PP1) reverse these effects to promote storage. Finally, the chapter connects these biochemical mechanisms to clinical pathologies by categorizing various glycogen storage diseases, such as Von Gierke, Pompe, and McArdle diseases, identifying the specific enzymatic defects and resulting symptoms associated with each.